Torrent Power share price: The company also experienced consistent revenue growth. For Q3 FY25, revenue from operations was Rs 6,499 crore, marking a 2% increase year-on-year from Rs 6,366 crore in Q3 FY24.
Sun Pharma deal structurally strong, debt the only overhang: Amit Khurana
Market expert Amit Khurana offers insights on key corporate and regulatory developments. Sun Pharma’s acquisition is seen as strategically sound, though debt requires careful management.